source
- FDA picks seven firms for PreCheck pilot to boost U.S. drug manufacturingThe FDA announced on June 29, 2026 that seven companies have been chosen for its PreCheck Pilot Program, an initiative aimed at strengthening U.S. drug manufacturing and supply chain resilience. T…
- Zymeworks CEO says $1 billion Theravance acquisition offers strong value despite recent setbacksZymeworks chief executive Kenneth Galbraith explained why the company believes its near-$1 billion purchase of Theravance makes strategic sense. He noted that Theravance has faced operational diff…